Do you have the same question? Follow this Question
Jun 19, 2025 - 09:56 AM
We’ve provided several answers to questions related to Moxeza Ophthalmic Solution (Moxifloxacin) , see some other helpful Q&A related to this product.
Question: Can contact lenses be worn during treatment with this product?
Answer: Contact lenses should not be worn if you have signs or symptoms of an eye infection. Removing contact lenses during treatment helps prevent further irritation or infection and ensures optimal healing conditions.
Question: What is the protein binding percentage of systemic moxifloxacin?
Answer: The protein binding percentage of systemic moxifloxacin is approximately 50%. This information is useful for understanding how the drug is distributed in the body and its potential interactions with other medications.
Question: What is the bioavailability of the ophthalmic solution?
Answer: The bioavailability of the ophthalmic solution is minimal systemic absorption. This feature ensures that the medication primarily acts locally in the eye, reducing the risk of systemic side effects.
Question: What is the dosage strength of the ophthalmic solution?
Answer: The dosage strength of the ophthalmic solution is 0.5% (5 mg/mL). This strength is effective for treating bacterial eye infections, providing targeted relief while minimizing the potential for systemic absorption.
View all Moxeza Ophthalmic Solution (Moxifloxacin) Questions & Answers
